Massage, Tub Bathing, and Sponge Bathing Effects on Neonatal Bilirubin and Comfort
NEO-BATH
Effects of Massage, Tub Bathing, and Sponge Bathing on Bilirubin Levels, Skin Barrier, Neonatal Comfort, and Vital Signs: A Randomized Clinical Trial
2 other identifiers
interventional
120
1 country
1
Brief Summary
This randomized controlled trial evaluates the effects of massage, tub bathing, and sponge bathing on bilirubin levels, skin integrity, neonatal comfort, and physiological parameters in term newborns undergoing phototherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 9, 2025
CompletedFirst Posted
Study publicly available on registry
July 25, 2025
CompletedJuly 25, 2025
July 1, 2025
1.3 years
July 9, 2025
July 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Serum Bilirubin Levels
Measured in mg/dL using standard laboratory testing
Baseline, 6 hours, 24 hours after intervention
Study Arms (4)
massage group
EXPERIMENTALNewborns receive standardized neonatal massages before phototherapy.
Tub Bath Group
EXPERIMENTALNewborns receive a warm water tub bath prior to phototherapy.
Sponge Bath Group
EXPERIMENTALNewborns receive a sponge (wipe) bath before phototherapy.
Control Group
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Receiving phototherapy
- Stable vital signs
- Parental consent
You may not qualify if:
- Congenital anomalies
- Severe infections or sepsis
- Parental refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bandırma Education and Research Hospital
Bandırma, Balıkesir, 10200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rukiye Öztürk
Uludag University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The study is open-label due to the nature of the interventions, which cannot be blinded.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- REGİSTERED NURSE
Study Record Dates
First Submitted
July 9, 2025
First Posted
July 25, 2025
Study Start
September 1, 2021
Primary Completion
January 1, 2023
Study Completion
August 1, 2024
Last Updated
July 25, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared to protect participant privacy and confidentiality.